Notably, a recent Egyptian randomized, prospective, interventional study in a few hospitalized patients with mild-to-moderate COVID-19 also obtained similar results [45], even though the authors employed lower doses of lactoferrin and a shorter treatment schedule than other non-randomized trials [25,38]. Here, LTF is linked to COVID-19.